FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jan. 7, 2009--MEDNAX, Inc., (NYSE:MD) today announced that it is scheduled to make a
presentation on Wednesday, January 14, at 8:30 a.m. Pacific Time, to
investors attending the 27th Annual J.P. Morgan Healthcare
Conference in San Francisco, CA.
The presentation by MEDNAX's Chief Executive Officer, Roger J. Medel,
M.D., will be broadcast through a live audio Webcast and will be
available for replay at www.mednax.com.
MEDNAX, Inc., through its subsidiaries, is a national medical group that
encompasses the nation's leading provider of neonatal, maternal-fetal
and pediatric physician subspecialty services as well as anesthesia
services. Physicians and advanced practitioners practicing as part of
MEDNAX are reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality
initiatives and clinical research to enhance patient outcomes and
provide high-quality, cost-effective care. Founded in 1979 as a neonatal
physician group, MEDNAX's Pediatrix subsidiary includes neonatal
physicians who provide services at more than 250 neonatal intensive care
units, and in many markets they collaborate with affiliated
maternal-fetal medicine, pediatric cardiology physician subspecialists
and pediatric intensivists to provide a clinical care continuum.
Pediatrix is also the nation's largest provider of newborn hearing
screens. American Anesthesiology includes more than 450
anesthesiologists and advanced practitioners. MEDNAX, through its
affiliated professional corporations, employs more than 1,200 physicians
in 32 states and Puerto Rico. Additional information is available at www.mednax.com.
CONTACT: MEDNAX, Inc., Fort Lauderdale
Bob Kneeley, Director, Investor Relations
954-384-0175, Ext. 5300
Source: MEDNAX, Inc.